---
layout: post
title: Cancer Cells CRISPR-Cas9 Large-scale Screens
subtitle: Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
#cover-img: /assets/img/nature_2019.png
thumbnail-img: /assets/img/nature_2019.png
share-img: /assets/img/nature_2019.png
#gh-badge: [star, fork, follow]
tags: [CRISPR-Cas9, Cancer Cell Lines, Precision Medicine, Biomarkers, WRN]
journal: Nature
comments: false
---

We presented one of the largest CRISPR-Cas9 screens available to date, and developed a precision oncology target prioritisation pipeline which screened 324 cancer cell lines and reported for the first time a synthetic-lethal interaction between microsatellite instability and WRN helicase.


### Reference
[Behan, Fiona M., Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M. Beaver, Giorgia Migliardi, Rita Santos, et al. 2019. “Prioritization of Cancer Therapeutic Targets Using CRISPR-Cas9 Screens.” Nature 568 (7753): 511–16.](https://doi.org/10.1038/s41586-019-1103-9)
